Vaccines & Immunity

Vaccination in Pregnancy: What the Evidence Says

Vaccination in Pregnancy: What the Evidence Says

Photo: FeaturingHealth.net | Healthy Living Simplified editorial

An evidence-based overview of vaccines commonly recommended during pregnancy and why timing matters — always discuss with your provider.

Key Takeaways

  • Two vaccines are routinely recommended during every pregnancy: Tdap and influenza.
  • Timing within pregnancy matters — Tdap is ideally given between weeks 27 and 36 of each pregnancy.
  • Maternal antibodies cross the placenta, offering newborns early protection before their own vaccinations begin.
  • Live vaccines such as MMR and varicella are generally deferred until after delivery.
  • Always consult your prenatal care provider before making any vaccination decision during pregnancy.

Why Pregnancy Is a Key Window for Immunization

Pregnancy creates a unique immunological opportunity. The placenta actively transports immunoglobulin G (IgG) antibodies from the pregnant person to the fetus, particularly in the third trimester. Vaccines given during this window trigger maternal antibody production that can cross to the baby, providing passive immunity during the months before the infant completes their own primary vaccination series.

This matters because some of the most dangerous infections for newborns — pertussis (whooping cough) and influenza among them — can cause severe complications in babies too young to have been vaccinated themselves. Immunizing during pregnancy is not a new concept; it is an established strategy embedded in U.S. prenatal care guidelines from the CDC and the Advisory Committee on Immunization Practices (ACIP).

For a broader picture of how vaccination fits across the lifespan, see our overview of immunization timelines from infancy to later life.

~90%

Reduction in infant pertussis hospitalizations

Studies published in peer-reviewed journals have associated maternal Tdap vaccination with substantial reductions in pertussis-related infant hospitalizations in the first two months of life.

~40%

Lower risk of flu hospitalization in infants

Research cited in CDC surveillance reports suggests infants born to vaccinated mothers have meaningfully lower rates of influenza-associated hospitalization in early life.

27–36

Optimal gestational weeks for Tdap

ACIP recommends this window for each pregnancy to maximize antibody transfer to the fetus before delivery.

Tdap (Tetanus, Diphtheria, Pertussis): ACIP recommends Tdap during every pregnancy, ideally between 27 and 36 weeks of gestation. Administering it in each pregnancy — rather than relying on prior vaccination — ensures the highest possible level of anti-pertussis antibodies reach the newborn before delivery. Pertussis is particularly dangerous in infants under two months old, who are too young to have received their own DTaP doses.

Influenza: An inactivated influenza vaccine is recommended for all pregnant individuals during any trimester of flu season. Pregnancy alters immune and cardiopulmonary function in ways that increase the risk of severe influenza complications, including hospitalization. The flu shot also passes antibodies to the newborn.

RSV (RSVpreF): The FDA approved an RSV vaccine for administration at 32–36 weeks of pregnancy to reduce the risk of severe lower respiratory tract disease in newborns and infants up to six months old. Eligibility guidance and seasonal timing recommendations continue to be refined; discuss this option directly with your provider.

COVID-19: The CDC recommends that pregnant individuals remain current with COVID-19 vaccination. Pregnancy is associated with an increased risk of severe COVID-19 illness and adverse pregnancy outcomes, and available safety surveillance has not identified pregnancy-specific concerns with authorized vaccines.

Vaccines Deferred Until After Delivery

Live attenuated vaccines — those that contain a weakened but replicating form of a pathogen — are generally not recommended during pregnancy as a precautionary measure. This category includes the MMR vaccine, the varicella (chickenpox) vaccine, and the combined MMRV vaccine. If a pregnant person is found to be non-immune to rubella or varicella during prenatal screening, vaccination is recommended promptly after delivery.

This deferral should not be misread as evidence that vaccines are broadly unsafe in pregnancy. The recommendation is precautionary and category-specific. Inactivated, subunit, and mRNA vaccines recommended during pregnancy have been evaluated in large safety monitoring systems and carry current approval for prenatal use.

If you have questions about prior immunization history or specific exposures, your prenatal provider or obstetrician is the right resource. Our article on separating vaccine myths from medical evidence addresses common concerns in more detail.

Talking With Your Provider and Staying Informed

Prenatal vaccination decisions should be made collaboratively with a qualified healthcare provider who knows your medical history, current pregnancy details, and local disease patterns. Individual circumstances — including chronic conditions, prior vaccination history, and gestational age — all bear on which vaccines are appropriate and when.

If you have family members who express hesitation about vaccines, evidence-based communication strategies can help. Our piece on talking with hesitant family members about vaccination provides approaches grounded in research.

Finally, the people around a newborn also play a role in protecting them through what public health practitioners call "cocooning" — ensuring that parents, siblings, grandparents, and caregivers are up to date on relevant vaccines, particularly Tdap. Our guide to adult immunization covers what's recommended for the adults in your household.

Timing Your Prenatal Vaccines Proactively

Ask your prenatal provider at your first appointment which vaccines are recommended and when in your pregnancy they are best administered. Building vaccination into your prenatal visit schedule — rather than treating it as an afterthought — makes it easier to hit the optimal timing windows, especially for Tdap at 27–36 weeks.

This article provides general health information and education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your prenatal care provider or a qualified healthcare professional regarding vaccination decisions during pregnancy.

Frequently Asked Questions

The CDC and ACIP currently recommend Tdap (tetanus, diphtheria, pertussis) and influenza vaccines during every pregnancy. Tdap is ideally given between 27 and 36 weeks of gestation. Influenza vaccination is recommended at any point during pregnancy, regardless of trimester.
Inactivated and subunit vaccines — including flu shots and Tdap — have an established safety record in pregnancy supported by decades of surveillance data and clinical research. As with all medical decisions in pregnancy, your provider is best positioned to weigh individual factors and current guidelines.
Recommended inactivated vaccines do not contain live virus and cannot cause infection in the fetus. The antibodies generated, however, do cross the placenta and provide the newborn with early passive protection. Live attenuated vaccines are deferred until after delivery as a precautionary measure.
The FDA approved an RSV vaccine (RSVpreF) for use during weeks 32–36 of pregnancy to protect newborns from severe RSV disease. ACIP guidance on this vaccine has evolved; speak with your provider about whether it is appropriate for your pregnancy and the current recommendation cycle.
The CDC has recommended that pregnant individuals stay up to date with COVID-19 vaccines. Evidence to date has not identified safety concerns specific to pregnancy, and infection during pregnancy carries elevated risk of severe illness and preterm birth. Discuss your individual situation with your prenatal provider.
Antibody levels wane over time, meaning protection transferred to the newborn is higher when the vaccine is given in each pregnancy rather than relying on prior immunization. The 27–36 week window allows the body enough time to generate a strong antibody response before delivery.

Preventive Health Editorial Team

FeaturingHealth.net | Healthy Living Simplified

Preventive Health Editorial Team is the collective byline for our editorial team and contributor network. Articles published under this byline or an editorial pen name are researched, written, and reviewed according to our editorial standards for clarity, consistency, and independence before publication.

Health ScreeningsPreventive HabitsVaccines & Immunity
View author profile

The content on this site is for informational purposes only and is not a substitute for professional advice. Always consult a qualified professional for guidance specific to your situation.